Presidio Partners 2007, L.P., 10% Owner at Neos Therapeutics, Inc. (NEOS), sold 57,968 shares at $10.16 ($593K) on 2016-04-13, disclosed to the SEC on 2016-04-15.
Open-market sale of $593k NEOS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.16 | 317 | $3K | 0.5% |
| 2 | $10.16 | 12,375 | $126K | 21.2% |
| 3 | $10.27 | 13,714 | $141K | 23.7% |
| 4 | $10.27 | 352 | $4K | 0.6% |
| 5 | $10.32 | 12,675 | $131K | 22.0% |
| 6 | $10.32 | 325 |
| $3K |
| 0.6% |
| 7 | $10.13 | 275 | $3K | 0.5% |
| 8 | $10.13 | 10,735 | $109K | 18.3% |
| 9 | $10.32 | 180 | $2K | 0.3% |
| 10 | $10.32 | 7,020 | $72K | 12.2% |
| Total | $10.23 avg | 57,968 | $593K | 100% |